Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Unresected stage III non-small-cell lung cancer....
Journal article

Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.

Abstract

GUIDELINE QUESTIONS: 1) What is the role of different schedules or doses of radiotherapy in patients with unresected, clinical or pathological, stage III non-small-cell lung cancer (NSCLC)? 2) Does chemotherapy combined with radiotherapy provide improved survival compared with radiotherapy alone in patients with unresected NSCLC? OBJECTIVE: To make recommendations about the role of chemotherapy and radiotherapy in the treatment of unresected …

Authors

Okawara G; Rusthoven J; Newman T; Findlay B; Evans W

Journal

Cancer prevention & control : CPC = Prévention & contrôle en cancérologie : PCC, Vol. 1, No. 3, pp. 249–259

Publication Date

August 1997

ISSN

1206-548X

Associated Experts

Andrew McIvor

Professor, Faculty of Health Sciences
Visit profile

Gordon Okawara

Associate Professor, Faculty of Health Sciences
Visit profile

James Rusthoven

Professor Emeritus, Faculty of Health Sciences
Visit profile

John Douglas Miller

Professor Emeritus, Faculty of Health Sciences
Visit profile

William Evans

Professor Emeritus, Faculty of Health Sciences
Visit profile

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences3211 Oncology and Carcinogenesis

Medical Subject Headings (MeSH)

Antineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Non-Small-Cell LungChemotherapy, AdjuvantCisplatinConfidence IntervalsDose Fractionation, RadiationHumansLung NeoplasmsMeta-Analysis as TopicNeoplasm StagingOutcome Assessment, Health CareProportional Hazards ModelsQuality of LifeRadiotherapy DosageRandomized Controlled Trials as TopicRisk FactorsSurvival Rate